Fadraciclib has passed safety trials and shown early efficacy
News
Amgen announces NHS collaboration aiming to tackle high cholesterol
Partnership will aim to prevent cardiovascular events across the North West Coast of England
European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine
Advance purchase agreement follows initial exploratory talks
Charities unite to highlight pandemic’s disruption to cancer services
Twenty charities representing people affected by rare and less common cancers launch ’20 for 20′ campaign
ABPI calls on UK government to create non-COVID clinical research strategy
New report finds UK is leading on early-stage clinical trials but needs strategy to restart non-COVID research
First-ever Patient Partnership Index Conference takes place
Senior leaders from patient organisations and the pharma industry came together to discuss best practice in patient partnerships
Gilead inks supply agreement with the European Commission for remdesivir
New agreement allows countries in the EU, EEA and the UK to purchase drug
EMA accepts filing for Biogen/Samsung Bioepis’ Lucentis biosimilar
Biosimilar is an anti-VEGF therapy for retinal vascular disorders
UK inks deal with Abingdon Health for rapid COVID-19 antibody tests
Government has placed first order for one million tests
Merck KGaA out-licenses osteoarthritis programme to Novartis
Potential disease modifying osteoarthritis candidate is phase II ready
Systematic benefit-risk study deems remdesivir a ‘favourable’ COVID-19 treatment
Study recorded all possible benefits and risks for COVID-19 patients receiving treatment
New drug shows potential for treating childhood neuroblastoma
Drug is ready to progress into clinical trials after passing initial safety test
ViiV’s two-drug HIV regimen demonstrates long-term efficacy
Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen
Uni of Manchester partners with AVROBIO for Hunter syndrome gene therapy
Investigational gene therapy was developed by professor Brian Bigger
Oncimmune/Medicines Discovery Catapult win UK government funding for COVID-19 research tool
Research tool will predict disease severity and therapeutic response
